| Ident. | Authors (with country if any) | Title |
|---|
| 000018 (2020) |
Uddalak Bharadwaj [États-Unis] ; Moses M. Kasembeli [États-Unis] ; Prema Robinson [États-Unis] ; David J. Tweardy | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution. |
| 000031 (2020) |
Qinghua Wu [République populaire de Chine, République tchèque] ; Wenda Wu [République populaire de Chine, République tchèque] ; Vesna Jacevic [République tchèque, Serbie] ; Tanos C C. Franca [République tchèque, Brésil] ; Xu Wang [République populaire de Chine] ; Kamil Kuca [République tchèque] | Selective inhibitors for JNK signalling: a potential targeted therapy in cancer. |
| 000062 (2020) |
Julie Girouard [Canada] ; Denise Belgorosky [Argentine] ; Jovane Hamelin-Morrissette [Canada] ; Valerie Boulanger [Canada] ; Ernesto D'Orio [Argentine] ; Djamel Ramla [Canada] ; Robert Perron [Canada] ; Lucie Charpentier [Canada] ; Céline Van Themsche [Canada] ; Ana Maria Eiján [Argentine] ; Gervais Bérubé [Canada] ; Carlos Reyes-Moreno [Canada] | Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways. |
| 000119 (2020) |
Masoud Farshbaf [Iran] ; Ahmad Yari Khosroushahi [Iran] ; Solmaz Mojarad-Jabali [Iran] ; Amir Zarebkohan [Iran] ; Hadi Valizadeh [Iran] ; Paul R. Walker [Suisse] | Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer. |
| 000127 (2020) |
Te-Fu Tsai [Taïwan] ; Po-Chun Chen [Taïwan] ; Yi-Chia Lin [Taïwan] ; Kuang-Yu Chou [Taïwan] ; Hung-En Chen [Taïwan] ; Chao-Yen Ho [Taïwan] ; Ji-Fan Lin [Taïwan] ; Thomas I-S Hwang [Taïwan] | Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells. |
| 000131 (2020) |
Dinghu Zhang [République populaire de Chine] ; Yanhong Chu [République populaire de Chine] ; Hanqing Qian [République populaire de Chine] ; Lingyu Qian [République populaire de Chine] ; Jie Shao [République populaire de Chine] ; Qiuping Xu [République populaire de Chine] ; Lixia Yu [République populaire de Chine] ; Rutian Li [République populaire de Chine] ; Quanan Zhang [République populaire de Chine] ; Fenglei Wu [République populaire de Chine] ; Baorui Liu [République populaire de Chine] ; Qin Liu [République populaire de Chine] | Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer. |
| 000179 (2019) |
Hyeon-Yeol Cho [États-Unis, Corée du Sud] ; Ahmet Mavi [Turquie] ; Sy-Tsong Dean Chueng [États-Unis] ; Thanapat Pongkulapa [États-Unis] ; Nicholas Pasquale [États-Unis] ; Hudifah Rabie [États-Unis] ; Jiyou Han [Corée du Sud] ; Jong Hoon Kim [Corée du Sud] ; Tae-Hyung Kim [Corée du Sud] ; Jeong-Woo Choi [Corée du Sud] ; Ki-Bum Lee [États-Unis, Corée du Sud] | Tumor Homing Reactive Oxygen Species Nanoparticle for Enhanced Cancer Therapy. |
| 000185 (2019) |
Fereshteh Shojaei ; Farshad Yazdani-Nafchi ; Mehdi Banitalebi-Dehkordi ; Mohammad Chehelgerdi ; Milad Khorramian-Ghahfarokhi [Iran] | Trace of survivin in cancer. |
| 000214 (2019) |
Maryam Rouhani [Iran] ; Samira Ramshini [Iran] ; Maryam Omidi [Iran] | The Psychiatric Drug Lithium Increases DNA Damage and Decreases Cell Survival in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines Expos ed to Ionizing Radiation. |
| 000254 (2019) |
Qingfei Wang [États-Unis] ; Ian H. Guldner [États-Unis] ; Samantha M. Golomb [États-Unis] ; Longhua Sun [États-Unis] ; Jack A. Harris [États-Unis] ; Xin Lu [États-Unis] ; Siyuan Zhang [États-Unis] | Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. |
| 000257 (2019) |
Kai Kang [République populaire de Chine] ; Yue Wang [République populaire de Chine] | Sevoflurane Inhibits Proliferation and Invasion of Human Ovarian Cancer Cells by Regulating JNK and p38 MAPK Signaling Pathway. |
| 000281 (2019) |
Chien-Hsing Lee [Taïwan] ; Chiung-Wei Huang [Taïwan] ; Po-Chih Chang [Taïwan] ; Jun-Ping Shiau [Taïwan] ; In-Pin Lin [Taïwan] ; Mei-Ying Lin [Taïwan] ; Chih-Cheng Lai [Taïwan] ; Chung-Yi Chen [Taïwan] | Reactive oxygen species mediate the chemopreventive effects of syringin in breast cancer cells. |
| 000302 (2019) |
Neda Soleimani [Iran] ; Akbar Vaseghi [Iran] ; Valentina Loconte [Italie] | Poliglusam Nanoparticles Activate T Cell Response in Breast Cancer Cell: an In Vivo and In Vitro Study. |
| 000318 (2019) |
Matteo Lambertini [Belgique] ; Florence Horicks [Belgique] ; Lucia Del Mastro [Italie] ; Ann H. Partridge [États-Unis] ; Isabelle Demeestere [Belgique] | Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. |
| 000350 (2019) |
Ji-Chang Wang [République populaire de Chine] ; Guang-Yue Li [République populaire de Chine] ; Bo Wang [République populaire de Chine] ; Su-Xia Han [République populaire de Chine] ; Xin Sun [République populaire de Chine] ; Yi-Na Jiang [République populaire de Chine] ; Yan-Wei Shen [République populaire de Chine] ; Can Zhou [République populaire de Chine] ; Jun Feng [République populaire de Chine] ; Shao-Ying Lu [République populaire de Chine] ; Jian-Lin Liu [République populaire de Chine] ; Mao-De Wang [République populaire de Chine] ; Pei-Jun Liu [République populaire de Chine] | Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation. |
| 000362 (2019) |
Bee Luan Khoo [Singapour] ; Gianluca Grenci [Singapour] ; Joey Sze Yun Lim [Singapour] ; Yan Ping Lim [Singapour] ; July Fong [Singapour] ; Wei Hseun Yeap [Singapour] ; Su Bin Lim [Singapour] ; Song Lin Chua [Singapour] ; Siew Cheng Wong [Singapour] ; Yoon-Sim Yap [Singapour] ; Soo Chin Lee [Singapour] ; Chwee Teck Lim [Singapour] ; Jongyoon Han [Singapour, États-Unis] | Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention. |
| 000383 (2019) |
Mohammed A. Alshehri [Arabie saoudite] ; Piotr M. Wierzbicki [Pologne] ; Hassan F. Kaboo [Égypte] ; Mohamed S M. Nasr [Égypte] ; Mohamed E. Amer [Égypte] ; Tamer M M. Abuamara [Égypte] ; Doaa A. Badr [Égypte] ; Kamel A. Saleh [Arabie saoudite] ; Ahmed E. Fazary [Égypte] ; Aly F. Mohamed [Égypte] | In vitro evaluation of electroporated gold nanoparticles and extremely-low frequency electromagnetic field anticancer activity against Hep-2 laryngeal cancer cells. |
| 000410 (2019) |
M T Jeena ; Keunsoo Jeong [Corée du Sud] ; Eun Min Go ; Yuri Cho [Corée du Sud] ; Seokyung Lee [Corée du Sud] ; Seongeon Jin ; Suk-Won Hwang [Corée du Sud] ; Joo Hee Jang [Corée du Sud] ; Chi Soo Kang [Corée du Sud] ; Woo-Young Bang [Corée du Sud] ; Eunji Lee [Corée du Sud] ; Sang Kyu Kwak ; Sehoon Kim [Corée du Sud] ; Ja-Hyoung Ryu | Heterochiral Assembly of Amphiphilic Peptides Inside the Mitochondria for Supramolecular Cancer Therapeutics. |
| 000446 (2019) |
Ji Eun Park [Corée du Sud] ; Joonyoung Park [États-Unis] ; Yearin Jun [Corée du Sud] ; Yunseok Oh [Corée du Sud] ; Gongmi Ryoo [Corée du Sud] ; Yoo-Seong Jeong [Corée du Sud] ; Hytham H. Gadalla [États-Unis] ; Jee Sun Min [Corée du Sud] ; Jung Hwan Jo [Corée du Sud] ; Myung Geun Song [Corée du Sud] ; Keon Wook Kang [Corée du Sud] ; Soo Kyung Bae [Corée du Sud] ; Yoon Yeo [États-Unis] ; Wooin Lee [Corée du Sud] | Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation. |
| 000457 (2019) |
Anshika N. Singh [Inde] ; Neeti Sharma [Inde] | Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer. |
| 000465 (2019) |
Gaili An [République populaire de Chine] ; Fang Wu [République populaire de Chine] ; Shangke Huang [République populaire de Chine] ; Lu Feng [République populaire de Chine] ; Jun Bai [République populaire de Chine] ; Shanzhi Gu [République populaire de Chine] ; Xinhan Zhao [République populaire de Chine] | Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages. |
